美股A股
StockGist
Back
8-K2026-03-25· x-ai/grok-4.1-fast

ANVS · Annovis Bio, Inc.

0001104659-26-034611

SEC filing

Summary

Annovis Bio, Inc. disclosed that Mark Guerin is no longer employed as Chief Financial Officer effective March 23, 2026, with no disagreement on operations, policies, or practices. The board anticipates appointing Maria Maccecchini, the Chief Executive Officer, as Acting Chief Financial Officer until a replacement is identified.

Key takeaways